POSSIBILITIES OF USING THE FLUORESCENCE IN SITU HYBRIDIZATION TECHNIQUE IN THE DIAGNOSIS OF BLADDER CANCER AND ITS RECURRENCES

V. B. Matveev; Матвеев В. Б.; A. I. Karseladze; Карселадзе А. И.; A. P. Kazaryan; Казарян А. П.; A. V. Khachaturyan; Хачатурян А. В.; B. Sh. Kamolov; Камолов Б. Ш.; O. V. Gigiadze; Гигиадзе О. В.; S. A. Kalinin; Калинин С. А.

doi:10.17650/1726-9776-2011-7-4-90-95

POSSIBILITIES OF USING THE FLUORESCENCE IN SITU HYBRIDIZATION TECHNIQUE IN THE DIAGNOSIS OF BLADDER CANCER AND ITS RECURRENCES

Authors: Matveev V.B.¹, Karseladze A.I.², Kazaryan A.P.³, Khachaturyan A.V.¹, Kamolov B.S.¹, Gigiadze O.V.³, Kalinin S.A.¹
Affiliations:
1. Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
2. Department of Pathologic Anatomy, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
3. Urology Department Fifteen, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Issue: Vol 7, No 4 (2011)
Pages: 90-95
Section: REVIEW
Published: 30.12.2011
URL: https://oncourology.abvpress.ru/oncur/article/view/228
DOI: https://doi.org/10.17650/1726-9776-2011-7-4-90-95
ID: 228

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Fluorescence in situ hybridization is a current technique to detect chromosomal specific genetic disorders specific to urinary bladder cancer (UBC). This technique may be used to diagnose UBC, to follow up patients after surgical treatment, to evaluate the efficiency of adjuvant therapy in these patients, and to predict the development of disease recurrence.

Keywords

bladder cancer, recurrent bladder cancer, fluorescence in situ hybridization, genetic disorders

About the authors

V. B. Matveev

Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences

Email: centrforward@mail.ru
Russian Federation

A. I. Karseladze

Department of Pathologic Anatomy, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences

Email: centrforward@mail.ru
Russian Federation

A. P. Kazaryan

Urology Department Fifteen, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: centrforward@mail.ru
Russian Federation

A. V. Khachaturyan

Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences

Author for correspondence.
Email: centrforward@mail.ru
Russian Federation

B. Sh. Kamolov

Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences

Email: centrforward@mail.ru
Russian Federation

O. V. Gigiadze

Urology Department Fifteen, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: centrforward@mail.ru
Russian Federation

S. A. Kalinin

Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences

Email: centrforward@mail.ru
Russian Federation

References

Supplementary files

Supplementary Files

Action

1. JATS XML

Download

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register